+100%-

Geoff’s Narrations

The GIST

 

How timely Dr. Da Silva’s presentation on “Delineating clinical phenotypes and HPA-axis dysfunction in ME/CFS” at the 2025 IACFS/ME conference was. Jose Philipe Da Silva is a neuroscientist based at the University of Amsterdam. We’ve just heard from a slew of studies that pointed arrows straight at the brain, and now we have an ME/CFS brain autopsy report. (Thanks to the IACFS/ME for their support in virtually attending the conference.)

IACFS-ME Conference

This is the third blog to emanate from the 2025 IACFS/ME Conference. More are coming.

Consider this – the Netherlands has done what the U.S. cannot – it started (in 2024) and is now delivering on an ME/CFS brain donor program. The NIH Neurobank is a huge brain donor program that encompasses ME/CFS. They were shocked at the interest shown by ME/CFS patients, and presumably have some ME/CFS brains, but what, if anything, has happened with them, we don’t know. )

 

Health Rising’s Quickie Summer Donation Drive is On!

Keeping up with the latest research in ME/CFS, long COVID, fibromyalgia, and allied diseases. Exploring new treatment possibilities. Learning how others have recovered. All in as thoroughly and comprehensively as we can. 

Please support Health Rising during our quickie summer donation drive. Our goal is to raise $15,000. 

 Find out more here.

The NIH Wants Your ME/CFS or Fibromyalgia Brain, A New Funding Opportunity and other takes from the NANDSC Roadmap Meeting

In the meantime, we have the Netherlands Brain Bank (NBB), a top-notch brain bank known for delivering high-quality, freshly harvested (terrible word) brains for research. According to the NBB website, researchers worldwide request brain tissue from the NBB each year.

These brain studies give us a unique slice (whoops, did it again) at ME/CFS. Thus far, autopsies have been done on 7 ME/CFS donors and more will be done. Each person had been diagnosed by an ME/CFS specialist, and the results were compared to matched controls who did not have ME/CFS.

It’s been almost seven years to the day since Health Rising last reported on autopsy reports in ME/CFS. A theme of dorsal root ganglionitis – damage to the neurons that transmit sensory signals to the spinal cord – prevailed.

Death in Chronic Fatigue Syndrome (ME/CFS) – What has it Told Us? The Autopsy Files

This report looked at a different area of the brain and found something equally interesting.

 

THE GIST

  • hypothalamus

    Could inflammation in the hypothalamus be playing a key role?

    How timely Dr. Da Silva’s presentation on “Delineating clinical phenotypes and HPA-axis dysfunction in ME/CFS” at the 2025 IACFS/ME conference was. We’ve just heard from a slew of studies that pointed arrows straight at the brain, and now we have an ME/CFS brain autopsy report.

  • It’s been almost seven years to the day since Health Rising last reported on autopsy reports in ME/CFS. A theme of dorsal root ganglionitis – damage to the neurons that transmit sensory signals to the spinal cord – prevailed.
  • Past brain autopsies have focused more on the brain stem, but this group, which specializes in the hypothalamus, started off at the HPA axis, which has been a focus of ME/CFS research almost from day one. Why? Because the HPA is the main stress-response and energy-regulation system in the body.
  • The hypothalamus, located at the bottom of the brain, senses stress, blood sugar levels, inflammation, time of day, and more. It releases corticotropin-releasing hormone to the pituitary gland, which then produces cortisol, which has been called our body’s “stress and energy manager”.
  • Cortisol mobilizes energy by raising blood sugar levels and helps us use fat and protein upon waking and during stressful periods. It also helps us stay alert and focused, and able to respond to threats or challenges and is an important anti-inflammatory, helps to constrict blood vessels, and affects memory, attention, motivation, and mood.
  • The Dutch group counted the neurons in the hypothalamus, did a gene expression analysis of the pituitary, and assessed cortisol levels. With the lower cortisol levels, they expected to see increased levels of neurons in the hypothalamus in order to up the production of CRH. It was all quite straightforward, they thought.
  • Something completely different, though, was going on. Instead of more CRH-producing neurons, they found almost no CRH producing neurons in the ME/CFS patients. That suggested that a general suppression of the hypothalamus had occurred, but the vasopressin and oxytocin neurons in the hypothalamus were either found at increased or normal levels. Only the CRH-producing neurons had been affected…
  • A gene expression analysis found more evidence of HPA axis trouble: the pituitary receptors that were designed to respond to numerous neuropeptides were down-regulated.
  • All in all, the HPA axis with the dramatic reduction of CRH-producing neurons in the hypothalamus, a shutdown of the pituitary, and lower cortisol levels found appeared to be pretty much of a wreck in these autopsied patients.
  • Note that this may represent a very severe end-stage of ME/CFS, only seven autopsies were performed, and note that people with milder illnesses may have more functional CRH neurons left.
  • Da Silva did not speculate on the cause. In 2020, though, Angus Mackay rather eerily conjectured – using a thought experiment – that the “stress integrator” in the hypothalamus called the paraventricular nucleus (PVN) may be playing a key role in ME/CFS. The PVN, it turns out, is the main producer of CRH.
  • Mackay proposed that an inflamed PVN might overproduce CRH. While this study found low numbers of CRH-producing neurons, Mackay’s hyperactive PVN scenario could result in long-term damage and the eventual disappearance of those neurons.
  • The situation seems all too familiar: it’s yet another version of the wired and tired / burnt out but stuck in threat mode problem that seems to pervade these diseases.
  • The recent (as yet unpublished) norepinephrine finding featured in a recent blog might be related to this. Dense strands of noradrenergic (norepinephrine-producing) fibers from the locus coeruleus reach straight into the PVN, where they trigger CRH production. Hyperactive NE neurons could trigger CRH neurons in the hypothalamus, causing them to burn out eventually in the most severe patients.
  • These findings suggest why adding cortisol in the form of low-dose hydrocortisone might sometimes have negative effects, if core portions of the cortisol-producing system are broken.
  • Interestingly, Cortene’s CT38  hypothesis might fit. Cortene proposed using a brief pulse of a CRFR2 agonist to reset the HPA axis. The idea is that chronic activation of the CRFR2 receptors could suppress the HPA axis, thereby blunting cortisol production. Interestingly, a chronically activated CRF system could also contribute to the hyperactivity observed recently in the locus coeruleus.
  • Interestingly, Cortene’s CT38 drug, if proven effective, might help by resetting the HPA axis and taking pressure off the hypothalamus.
  • The autopsy data – which may come from very severe patients – could also fit a picture where chronic neuroinflammation in limbic/PVN/brainstem areas slowly erodes core stress-regulation regions there. In this scenario, the NE-producing neurons in the locus coerleus, the CRH-producing neurons in the hypothalamus, and the adrenals are all hit, and the two major stress response systems (HPA axis, autonomic nervous system) are clobbered.
  • Treatments to tamp down neuroinflammation, calm the immune system, and turn off the danger response might help.
  • We should expect more from the Dutch effort and the NIH’s RECOVER project already, get this, over 250 long- COVID patients in its autopsy bank and plans to include about 350. The possibilities for learning are immense.

 

Donation Drive Update

thinking piggy

The connections appear to be piling up…

Thanks to the over 100 people who have contributed almost $10K to Health Rising’s year-end drive!

This blog demonstrates a couple of Health Rising’s strengths. One, a commitment to keep up with the latest research findings, and two, a commitment to integrate, if possible, past findings into current ones. In this blog, for instance, we saw that it’s possible – not proven – but possible that the low NE findings from an earlier blog could match up with the low CRH findings in the autopsy reports. It was also nice to see Cortene pop up again as a possibility. Finally, these findings suggest we have a lot to look forward to as the Recover Initiative gears up its massive long-COVID autopsy project.

If that floats your boat, please support us!

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

A Hypothalamic-Pituitary-Adrenal (HPA) Axis Focus

Past brain autopsies have focused more on the brain stem, but this group, which specializes in the hypothalamus, started off at the HPA axis, which has been a focus of ME/CFS research almost from day one. Why? Because the HPA is the main stress-response and energy-regulation system in the body.

The hypothalamus, located at the bottom of the brain, senses stress, blood sugar levels, inflammation, time of day, and more. It releases corticotropin-releasing hormone to the pituitary gland – which is found just below the brain – which then releases ACTH into the bloodstream. ACTH travels through the bloodstream all the way down to the adrenal glands (on top of the kidneys).

The end result is the production of cortisol, which has been called our body’s “stress and energy manager.” Cortisol mobilizes energy by raising blood sugar levels and helps us use fat and protein upon waking and during stressful periods.

It helps us stay alert and focused, and able to respond to threats or challenges. It’s also an important anti-inflammatory, helps constrict blood vessels, and affects memory, attention, motivation, and mood.

Studies have shown that morning salivary cortisol levels are low in ME/CFS. Akiko Iwasaki’s big long-COVID study rather shockingly found that it was low cortisol instead to T or B-cell, or an autoimmune process, that was “hugely predictive” for long COVID.

The Hugely Predictive Factor for Long COVID…is also found in ME/CFS and Fibromyalgia: the IACFS/ME Conference II

That was a bit of a shock. While HPA axis studies continued in ME/CFS, I don’t think anyone thought that low cortisol might be so predictive. The ever-increasing complexity of these studies and the data analytic techniques used means new insights are liable to pop out. (The Iwasaki group was critiqued for how they did the initial cortisol testing but redid them and got the same result.)

The Dutch group counted the neurons in the hypothalamus, did a gene expression analysis of the pituitary, and assessed cortisol levels. With the lower cortisol levels, they expected to see increased levels of neurons in the hypothalamus in order to up the production of CRH. It was all quite straightforward, they thought.

Producing CRH – The hypothalamus detects cortisol levels in the bloodstream via glucocorticoid receptors, which latch onto the cortisol. If too few GRs are activated, the brakes on cortisol production are taken off, and the hypothalamus produces more CRH. Given the low cortisol levels in ME/CFS, it only made sense that the hypothalamus would be trying to compensate by producing more CRH-producing neurons.

Surprise!

Except it wasn’t in the ME/CFS patients. Something completely different was going on. Instead of more CRH-producing neurons, they found almost no CRH-producing neurons in the ME/CFS patients. An image (embargoed) showed what was essentially a blank screen with a few faint scuff marks (the CRH producing neurons). Given that, it was not surprising to see dramatically lower CRH levels in the fibers projecting to the pituitary.

hypothalamus

To their surprise, the researchers found very low levels of CRH-producing neurons in the hypothalamus of autopsied ME/CFS patients.

That suggested that a general suppression of the hypothalamus had occurred, but then they were stumped again. The vasopressin and oxytocin neurons in the hypothalamus were either found increased or at normal levels. Only the CRH-producing neurons had been affected…

Going down the HPA axis loop, they found much the same. A gene expression analysis found that pituitary receptors designed to respond to neuropeptides were down-regulated.

The pituitary responds to a lot of neuropeptides (CRH (corticotropin-releasing hormone) AVP / vasopressin, TRH (thyrotropin-releasing hormone), GnRH (gonadotropin-releasing hormone), GHRH (growth hormone–releasing Hormone), somatostatin, dopamine (from the hypothalamus)). The production of POMC, a “mother” peptide or prohormone that gets chopped into ACTH, was also downregulated. Decades ago, ME/CFS studies found that the pituitary in ME/CFS was not responding correctly to CRH.

Note that low CRH levels can affect more than cortisol. Low CRH levels could also affect arousal, “stress readiness”, produce feelings of being “jittery but weak” via autonomic nervous system dysfunction, increase pain, gut problems, poor sleep, and more. Reduced pituitary receptor activity could lead to increased pain, reduced libido, increased sensitivity to cold, etc.

All in all, the HPA axis with the dramatic reduction of CRH-producing neurons in the hypothalamus, a shutdown of the pituitary, and lower cortisol levels appeared to be pretty much of a wreck in these autopsied patients.

Since the final result of this pretty smashed-up HPA axis is to produce cortisol, the researchers looked for evidence of cortisol suppression, and found it. They are now looking for evidence of low plasma cortisol levels.

Note that this may represent a very severe end-stage of ME/CFS, that only seven autopsies were performed, and that people with milder illnesses may have more functional CRH neurons left.

Back to the Future?

The speaker noted that low cortisol levels can at least partially explain many of the core symptoms (fatigue, sleep, others) found in ME/CFS. So we appear to be back at the HPA axis.

Da Silva did not speculate on the cause. While this finding has not been published, and only 7 autopsies have been done, it’s worthwhile to ask what could be causing this strange HPA axis dysfunction and whether it fits with what else we know about ME/CFS? Also, what could the possible pituitary problems produce?

First, note that the hypothalamus has attracted considerable interest over time. Back in 2014, Dr. Bateman focused on inflammation in the thalamus, hypothalamus, and pituitary. In 2018, Theoharides proposed that mast cells in the hypothalamus were pouring out neuro-inflammatory factors that opened up the blood-brain barrier, whacked the mitochondria, and caused neuroinflammation at the same time.

In 2020, Angus Mackay rather eerily conjectured – using a thought experiment – that the “stress integrator” in the hypothalamus called the paraventricular nucleus (PVN) may be playing a key role in ME/CFS. The PVN, it turns out, is the main producer of CRH.

A Novel Neuroinflammatory Paradigm for Chronic Fatigue Syndrome (ME/CFS)

Mackay proposed that an inflamed PVN might overproduce CRH. While this study found low numbers of CRH-producing neurons, Mackay’s hyperactive PVN scenario could result in long-term damage and the eventual disappearance of those neurons.

The situation seems all too familiar: it’s yet another version of the wired and tired / burnt out but stuck in threat mode problem that seems to pervade these diseases.

But why would only CRH-producing neurons in the hypothalamus be affected? Perhaps because vasopressin and oxytocin-producing neurons at least in part occur in different parts of the PVN. Various hypotheses have been put forth regarding adrenal dysfunction, but in this scenario, the adrenal functioning might be impaired because they are “under-stressed”.

It shouldn’t go unnoticed that the recent (as yet unpublished) norepinephrine finding might be related to this. Dense strands of noradrenergic (norepinephrine-producing) fibers from the locus coeruleus reach straight into the PVN, where they trigger CRH production. The hyperdrive present in the NE neurons could produce hyperactive CRH neurons in the hypothalamus, which eventually burn out.

Role Reversal: Could a WEAKENED Fight/Flight Response Be Causing ME/CFS and Long COVID? The 2025 IACFS/ME Conference Pt. I

These findings suggest why adding cortisol in the form of low-dose hydrocortisone might sometimes have negative effects, if core portions of the cortisol-producing system are broken.

Interestingly, Cortene’s CT38 hypothesis might fit. Cortene proposed using a brief pulse of a CRFR2 agonist to reset the HPA axis. The idea is that chronic activation of the CRFR2 receptors could suppress the HPA axis, thereby blunting cortisol production. Interestingly, a chronically activated CRF system could also contribute to the hyperactivity observed recently in the locus coeruleus.*

The Cortene Drug Trial Results for ME/CFS Are In

The autopsy data – which may come from very severe patients – could also fit a picture where chronic neuroinflammation in limbic/PVN/brainstem areas slowly erodes core stress-regulation regions there. In this scenario, the NE-producing neurons in the locus coerleus, the CRH-producing neurons in the hypothalamus, and the adrenals all get hit, and the two major stress response systems (HPA axis, autonomic nervous system) get clobbered. Things are at their nadir when exhausted neurons begin to disappear.

The study found that some neurons remained, and it’s possible that others were too shrunken to appear. While neuron regeneration in the central nervous system can occur, it’s limited. Reducing inflammation, taking the pedal off the stress response, and using CT38 to reset the HPA axis could conceivably provide substantial compensation.

Treatment?

We always seem to end up talking about inflammation, which is actually good news, since fighting inflammation is such a big topic in the medical field. If neuroinflammation is driving this HPA axis disruption, several approaches could help.

hypothalamus

Could inflammation in the hypothalamus be playing a key role?

We don’t appear to have any great neuroinflammation busters right now, but a number of treatments (minocycline, GLP-1 agonists, mast cell stabilizers, low-dose naltrexone, PEA, vagus nerve stimulation, cytokine blockers like etanercept) could help in that regard. The effects of Ibudilast, NLRP3 inhibitors, CNS BTK inhibitors, and TREM2 agonists on neuroinflammation are being assessed. By plumping up the prefrontal cortex, rTMScould take stress off locus coeruleus neurons. Baricitinib and other JAK inhibitors (e.g., REVERSE-LC) and drugs like bezisterim may indirectly help by calming the immune response.

Neuroplasticity practices may be able to tone down the danger response in some people, allowing the system to reset. I’ve heard reports that Bob Naviaux’s Suramin trial to turn off the danger response may be getting underway.

We’ve had some exciting reports from the IACFS/ME conference which appear to fit together well. Note that we are still awaiting publication of these studies, and the Dutch study was quite small – so time will tell. We should be hearing more from them as they assess more patients and explore more parts of the brain.

The big elephant in the autopsy room is the RECOVER Initiative which already has, get this, over 250 long-COVID patients to autopsy and plans to autopsy around 350.

*I am a board member of Cortene.

Donation Drive Update

Thanks to the over 100 people who have contributed almost $10K to Health Rising’s year-end drive!

This blog demonstrates a couple of Health Rising’s strengths. One, a commitment to keep up with the latest research findings, and two, a commitment to integrate, if possible, past findings into current ones. In this blog, for instance, we saw that it’s possible – not proven – but possible that the low NE findings from an earlier blog could match up with the low CRH findings in the autopsy reports. It was also nice to see Cortene pop up again as a possibility. Finally, these findings suggest we have a lot to look forward to as the Recover Initiative gears up its massive long-COVID autopsy project.

If that floats your boat, please support us!

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

 

Health Rising’s Quickie Summer Donation Drive is On!

Keeping up with the latest research in ME/CFS, long COVID, fibromyalgia, and allied diseases. Exploring new treatment possibilities. Learning how others have recovered. All in as thoroughly and comprehensively as we can. 

Please support Health Rising during our quickie summer donation drive. Our goal is to raise $15,000. 

 Find out more here.

Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest

Share This